Constellium SE

CSTM remains in a Stage 4 decline with medium-term bearish asymmetry confirmed by active Support Failure and sequential lower highs & lower lows beneath declining EMAs. RSI is in Extreme Oversold territory, indicating high relief-bounce risk, which makes immediate selling unfavorable. We will defer execution and trim into rallies toward the declining 9, 20, and 50 EMA zone and prior support-turned-resistance around those levels.

• ↑24% YoY revenue growth to $2.5B in Q1 2026; adjusted EBITDA +93% to $359M
• ↑Issued full-year EBITDA forecast of $900–940M and free cash flow >$275M
• ↓European luxury and premium auto weakness risks automotive segment sales